Synthetic Virus-Like Particles: The Future of Targeted Drug Delivery
Overview
Cell-selective drug delivery can overcome the downfalls of non-specific cancer therapies, such as systemic toxicity and low effectiveness. Previous research has revealed that properly modified peptides derived from the second transmembrane domain of the CXCR4 chemokine receptor inhibit receptor function and have the remarkable capability to self-assemble into homogeneous virus-like particles that fuse with cells spontaneously. Particle modification with receptor ligands would allow for receptor-mediated cell fusion and selective cell delivery. The goal of this project is to determine structural mechanisms of particle formation and generate highly selective delivery systems with multiple therapeutic applications. Studies have shown that synthetic analogs of three chemokine receptors, CCR4, CCR3, and CCR8 self-assemble into stable particles with the radii ranging from 5.7 to 9.7 nanometers. Dynamic light scattering has shown the particles to be highly homogeneous, and spherical particles were further confirmed by electron microscopy studies. Microscale Thermophoresis and Fluorescence Polarization determined critical assembly concentration to be within the nanomolar range indicating high efficacy of the assembly. Melting temperature for all particles determined by Differential Scanning Fluorimetry was around 70 degrees Celsius further confirming high stability. The data strongly suggest that self-assembly is a general property of analogs of the second transmembrane domain of chemokine receptors. Synthetic self-assembling antagonists are promising drug leads and delivery systems for targeting receptors critical to disease signaling pathways. They represent a novel concept in drug development: a multifunctional therapeutic that delivers itself to a specific target.
Awards (1)
- American Committee for the Weizmann Institute of Science: Alternate for trip
Competition history
- ISEF 2019
Resources
Related projects
ISEF · 2024
Self-Assembling Chimeric Polypeptides as Drug-Carrying Nanoparticles for Anti-Cancer Chemotherapy
ISEF · 2018
Effective Evasion of Chemotherapeutic Resistance by Functionalized Viral Capsid QB
ISEF · 2015
Increasing Cancer-Specific Drug Delivery using Targeted Liposomes
ISEF · 2015
Development of a Nanoparticle for Targeted Antigen Delivery as a Therapeutic Vaccination Platform
ISEF · 2016
The Optimization of Nanoparticle-Based Drug Delivery of Melittin in a Colloidal Suspension as a Selective Method to Target HIV Structural Antigen p24
ISEF · 2021
Targeted Core-Shell Nanoassembly Composed of a Mesoporous Silica Core, Liposome Shell, and GE11 Peptide as a Drug Delivery Nanocarrier
ISEF · 2025
Engineering DNA Nanocrystals for Trigger-Responsive Drug Delivery: A Biocompatible Approach to Nanomedicine
ISEF · 2017
Investigating the Design of Nanoparticles to Target Difficult-to-Reach Tumors
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair